Similarly, Comuzzi and coworkers reported that CBP is up-regulated as a consequence of androgen withdrawal in patients with advanced PCa and suggested that under androgen-deprived conditions, CBP can mediate aberrant AR activity which could explain the failure of endocrine therapy in late-stage PCa (50). This evidence concerns the gene AR and posterior cortical atrophy.